The industry is rapidly changing, which provides a unique set of challenges for those developing and manufacturing biosimilars and generic medicines. Gain true insight on winning development, manufacturing, clinical and commercialisation strategies for biosimilars and generics in the global market.

Navigate the challenges in the clinic, the manufacture and development of biosimilar and generic medicines as well as explore the commercial aspects of the industry. This is your best chance to find out where the industry growth opportunities lie and what role they can play in your portfolio.


Heads of:

  • HTA 

  • Market Access 

  • Health Economics 

  • Outcomes Research 

  • Health Policy 

  • Epidemiology 

  • Pricing & Reimbursement

  • Pharmacoeconomics 

  • Clinical trials 

  • Clinical research 

  • Post marketing Surveillance 

  • Medical Affairs 

  • Pharmacoepidemiology


  • Discover new reimbursement models which are impacting market access

  • Stay abreast of important Market Access trends and updates from across the globe

  • Hear from leading international HTA agencies

  • Learn from case studies on demonstrating product value

  • Understand the payers’ perspective

  • Discuss how to generate, apply and present ‘real world’ evidence to maximise patient access

  • Analyse and compare pricing and partnering models

  • Gain best practice insights for market access of high value and orphan drugs in the multi speaker focus day

  • Leverage evidence planning and payer strategy for optimum pricing, market access and launch

  • Network with pioneers, influencers and innovators and return to your company with new ideas and relationships





Agenda attendees